TMO - Thermo Fisher Scientific Inc.
| Previous Close | 236.34 |
| Open | 236.74 |
| Bid | 236.89 x 200 |
| Ask | 236.97 x 100 |
| Day's Range | 235.56 - 238.42 |
| 52 Week Range | 181.51 - 249.95 |
| Volume | 440,027 |
| Avg. Volume | 1,473,193 |
| Market Cap | 95.149B |
| Beta (3Y Monthly) | 1.33 |
| PE Ratio (TTM) | 37.29 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.68 (0.28%) |
| Ex-Dividend Date | 2018-12-14 |
| 1y Target Est | N/A |
- CNBC Videos•20 hours ago
Chartmaster says amid the market sell-off these are the b...
Carter Worth, Cornerstone Macro, on quality bear-market stocks to buy. With CNBC's Joe Kernen and the Fast Money traders, Pete Najarian, Steve Grasso, Brian Kelly and Tim Seymour.
- Motley Fool•22 hours ago
Becton, Dickinson Closes Out Its Fiscal Year With a Bang
Next year's revenue may not be so hot, but earnings should grow nicely as the company captures synergies and pays down debt.
- Investor's Business Daily•4 days ago
Highly Rated 'Surgeon' For Biologic-Drug Makers Soars 85% In 2018
Repligen stock is on a rampage this year as it outperforms broad medical-products stocks. The bioprocessing firm has completely transformed, its CEO says.
- Barrons.com•6 days ago
Democrats Could Take Aim at Tax Cuts, Says Dan Clifton
Strategas’ policy research director calls health care the midterms’ big winner—but he warns that Democrats could threaten profits if they try to roll back tax cuts.
- Zacks•6 days ago
Illumina (ILMN) Inks $1.2B Deal to Buy Pacific Biosciences
Illumina (ILMN) taking out on its peer, in the $1.2-billion acquisition deal, will further strengthen the position of the former in the genomics market.
Markit•11 days agoSee what the IHS Markit Score report has to say about Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc NYSE:TMO
- Zacks•13 days ago
Zacks.com highlights: Dick's Sporting Goods, Microsoft, Matson, Thermo Fisher Scientific and Progressive
Zacks.com highlights: Dick's Sporting Goods, Microsoft, Matson, Thermo Fisher Scientific and Progressive
- American City Business Journals•14 days ago
GE is no longer the most valuable public company in Massachusetts
On Aug. 22, 2016, the day GE officially became a Massachusetts-based company, it had a market cap that was greater than the next six most valuable companies in the state combined. Not anymore.
- Simply Wall St.•15 days ago
A Note On Thermo Fisher Scientific Inc’s (NYSE:TMO) ROE and Debt To Equity
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Read More...
- Zacks•15 days ago
The Zacks Analyst Blog Highlights: McDonald's, Thermo Fisher, Caterpillar, CSX and Celgene
The Zacks Analyst Blog Highlights: McDonald's, Thermo Fisher, Caterpillar, CSX and Celgene
Markit•17 days agoSee what the IHS Markit Score report has to say about Thermo Fisher Scientific Inc.
To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- American City Business Journals•18 days ago
The October stock crash has wiped out $45.5B from Mass. health firms
The health care and life sciences sector accounts for around 42 percent of all Massachusetts-based public companies.
- Zacks•18 days ago
Top Research Reports for McDonald's, Thermo Fisher & Caterpillar
Top Research Reports for McDonald's, Thermo Fisher & Caterpillar
- Thomson Reuters StreetEvents•19 days ago
Edited Transcript of TMO earnings conference call or presentation 24-Oct-18 12:30pm GMT
Q3 2018 Thermo Fisher Scientific Inc Earnings Call
Markit•19 days agoSee what the IHS Markit Score report has to say about Thermo Fisher Scientific Inc.
To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- Investor's Business Daily•20 days ago
Highly Rated Medical-Research Stock Beats Quarterly Estimates
Thermo Fisher Scientific beat quarterly expectations Wednesday and issued consensus-topping 2018 guidance — prodding shares to jump as much as 7%.
Motley Fool•20 days agoThermo Fisher Scientific Inc (TMO) Q3 2018 Earnings Conference Call Transcript
TMO earnings call for the period ending September 29, 2018.
- Market Realist•20 days ago
Thermo Fisher Beats Analysts’ Estimates in Q3 2018 Earnings
Thermo Fisher Scientific (TMO) reported its third quarter of 2018 results today, October 24. It surpassed Wall Street analysts’ estimates for both EPS and revenue. Its non-GAAP EPS was $2.62, and its revenues were $5.92 billion. That compares to analysts’ EPS estimate of $2.55 on revenues of $5.7 billion.
- Zacks•20 days ago
Thermo Fisher (TMO) Beats on Q3 Earnings, Ups '18 Guidance
Thermo Fisher (TMO) raises its 2018 revenue view, banking on a solid third-quarter operational performance, partially offset by a less favorable foreign exchange.
- Investing.com•20 days ago
Thermo Fisher Scientific Earnings, Revenue Beats In Q3
Investing.com - Thermo Fisher Scientific (NYSE:TMO) reported third quarter earnings and revenue that topped forecasts on Wednesday.
- Zacks•20 days ago
Thermo Fisher Scientific (TMO) Beats Q3 Earnings and Revenue Estimates
Thermo Fisher (TMO) delivered earnings and revenue surprises of 2.75% and 3.93%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press•20 days ago
Thermo Fisher: 3Q Earnings Snapshot
The Waltham, Massachusetts-based company said it had profit of $1.75 per share. Earnings, adjusted for one-time gains and costs, were $2.62 per share. The results surpassed Wall Street expectations. The ...
- Reuters•20 days ago
Thermo Fisher raises forecast after third-quarter profit beat
Thermo Fisher Scientific Inc reported a better-than-expected quarterly profit on Wednesday on higher demand for its laboratory products and the world's largest scientific instruments maker raised its full-year ...
- Benzinga•21 days ago
Q3 Earnings Preview: Thermo Fisher Scientific
On Wednesday, Thermo Fisher Scientific (NYSE: TMO ) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release. Earnings and Revenue Thermo ...
- Zacks•21 days ago
Medical Products Q3 Earnings on Oct 24: BSX, ALGN & More
Long-term potential of the Medical Products industry appears promising at the moment amid certain short-term geopolitical insecurities.
